Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemia

Cancer Genetics

Volumn 206, Issue 1-2, 2013, Pages 19-25

  Véronèse, Lauren ^a,b,c   Tournilhac, Olivier ^a,b   Combes, Patricia ^a,b,c   Prie, Nolwen ^a,b,c   Pierre Eymard, Eléonore ^a,b,c   Guièze, Romain ^a,b   Veyrat Masson, Richard ^a,b   Bay, Jacques Olivier ^a,b   Vago, Philippe ^a,b,c   Tchirkov, Andreï ^a,b,c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CENTRE JEAN PERRIN   (France)

Author keywords

CLL; Interphase FISH; MLPA; Recurrent genomic aberrations

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME 19; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; COPY NUMBER VARIATION; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POINT MUTATION; PRIORITY JOURNAL; RECURRENT DISEASE; TRISOMY 18; TRISOMY 19; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GENE FREQUENCY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 84873481703     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.12.002     Document Type: Article

References (19)

1. Juliusson G., Oscier D.G., Fitchett M., et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990, 323:720-724.
2. Döhner H., Stilgenbauer S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916.
3. Haferlach C., Dicker F., Schnittger S., et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007, 21:2442-2451.
4. Chapiro E., Leporrier N., Radford-Weiss I., et al. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages. Leuk Res 2010, 34:63-68.
5. Novak U., Oppliger Leibundgut E., Hager J., et al. A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL). Blood 2002, 100:1787-1794.
6. Schwaenen C., Nessling M., Wessendorf S., et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad USA 2004, 101:1039-1044.
7. Nguyen-Khac F., Chapiro E., Lesty C., et al. Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia. Am J Blood Res 2011, 1:13-21.
8. Put N., Van Roosbroeck K., Konings P., et al. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol 2012, 91:863-873.
9. Sellmann L., Gesk S., Walter C., et al. Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia. Br J Haematol 2007, 138:217-220.
10. Hallek M., Cheson B.D., Catovsky D., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111:5446-5456.
11. Schouten J.P., McElgunn C.J., Waaijer R., et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30:e57.
12. Coll-Mulet L., Santidrian A.F., Cosialls A.M., et al. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Br J Haematol 2008, 142:793-801.
13. Stevens-Kroef M., Simons A., Gorissen H., et al. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification. Cancer Genet Cytogenet 2009, 195:97-104.
14. Al Zaabi E.A., Fernandez L.A., Sadek I.A., et al. Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience. J Mol Diagn 2010, 12:197-203.
15. Abdool A., Donahue A.C., Wohlgemuth J.G., et al. Detection, analysis and clinical validation of chromosomal aberrations by multiplex ligation-dependent probe amplification in chronic leukemia. PLoS One 2010, 5:e15407.
16. Fabris S., Scarciolla O., Morabito F., et al. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. Genes Chromosomes Cancer 2011, 50:726-734.
17. Stilgenbauer S., Bullinger L., Lichter P., et al. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002, 16:993-1007.
18. Zenz T., Vollmer D., Trbusek M., et al. TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia 2010, 24:2072-2079.
19. Coll-Mulet L., Gil J. Genetic alterations in chronic lymphocytic leukaemia. Clin Transl Oncol 2009, 11:194-198.